George L. Bakris, MD; Michael Berkwits, MD, MSCE, Deputy Editor
Potential Financial Conflicts of Interest:Consultancies: G.L. Bakris (Merck, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Abbott Laboratories, Forest Pharmaceuticals).
Grants received: G.L. Bakris (National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, GlaxoSmithKline, Forest Pharmaceuticals).
Grants pending: G.L. Bakris (National Institutes of Health Alternative Medicine Institute). Royalties: G.L. Bakris (Dr. Bakris is the editor of many textbooks on hypertension).
Corresponding Author: Michael Berkwits, MD, MSCE, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.
Current Author Addresses: Dr. Bakris: University of Chicago, 924 East 57th Street, Suite 104, Chicago, IL 60637.
Dr. Berkwits: American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.
Bakris GL, Berkwits M. Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes. Ann Intern Med. 2008;148:400–401. doi: https://doi.org/10.7326/0003-4819-148-5-200803040-00012
Download citation file:
Published: Ann Intern Med. 2008;148(5):400-401.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Hypertension.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use